N
Nocipain
NOCI develops an FDA-cleared Class II platform for objective pain measurement utilizing a clinical-grade wearable and AI interpretation. This system provides continuous physiological monitoring anchored to patient reporting for structured, longitudinal pain signals. The platform aims to support medical decision-making for more accurate chronic pain diagnosis and treatment.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- NOCI develops an FDA-cleared Class II platform for objective pain measurement utilizing a clinical-grade wearable and AI interpretation. This system provides continuous physiological monitoring anchored to patient reporting for structured, longitudinal pain signals. The platform aims to support medical decision-making for more accurate chronic pain diagnosis and treatment.